Proposed placing

10th March 2021

Cambridge, UK – 10 March 2021: Nuformix plc (LSE:NFX), a pharmaceutical development company and drug re-purposing specialist, is pleased to announce that it has conditionally raised £1.565 million before expenses (the “Placing”) by way of a placing of 78,250,000 new ordinary shares of nominal value 0.1 pence each (“Ordinary Shares”) in the capital of the Company (the “Placing Shares”) at a price of 2 pence per share (the “Placing Price”).

Download News

Back to all News